Stocks and Investing Stocks and Investing
Tue, November 21, 2023
Mon, November 20, 2023

Joseph Pantginis Reiterated (BLRX) at Strong Buy and Held Target at $21 on, Nov 20th, 2023


Published on 2024-10-28 07:40:33 - WOPRAI, Joseph Pantginis
  Print publication without navigation


Joseph Pantginis of HC Wainwright & Co., Reiterated "BioLineRx Ltd." (BLRX) at Strong Buy and Held Target at $21 on, Nov 20th, 2023.

Joseph, nor any peers, have made any analyst calls on BLRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources